| Date | Source | Headline | |
|---|---|---|---|
| 28th Feb 2022 | 7:00 am | RNS | Direct to Consumer market launch in New York |
| 21st Jan 2022 | 7:00 am | RNS | Appointment of Chief Financial Officer |
| 17th Jan 2022 | 7:00 am | RNS | Clinical research update on GRITT(tm) methodology |
| 4th Jan 2022 | 7:00 am | RNS | Directorate Change |
| 20th Dec 2021 | 3:44 pm | RNS | Issue of Equity |
| 14th Dec 2021 | 7:00 am | RNS | Trading update |
| 22nd Sep 2021 | 7:00 am | RNS | Half-year Report |
| 16th Sep 2021 | 7:00 am | RNS | New Partnership Agreement & Licensed Clinical Team |
| 9th Sep 2021 | 7:00 am | RNS | Notice of Results |
| 23rd Aug 2021 | 7:00 am | RNS | First Demonstration Programme Contract |
| 11th Jun 2021 | 4:40 pm | RNS | Second Price Monitoring Extn |
| 11th Jun 2021 | 4:35 pm | RNS | Price Monitoring Extension |
| 2nd Jun 2021 | 3:50 pm | RNS | Holding(s) in Company |
| 28th May 2021 | 2:05 pm | RNS | Second Price Monitoring Extn |
| 28th May 2021 | 2:00 pm | RNS | Price Monitoring Extension |
| 28th May 2021 | 7:00 am | RNS | Admission to AIM and First Day of Dealings |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.